AŞAdnan Şimşir

Adnan Şimşir

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adnan Şimşir has a total of 135 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Upper Urinary System Changes After Radical Cystectomy and Bricker Urinary Diversion: A Retrospective Evaluation of Functional and Radiological Parameters

    by Alp Akyol, Kasim Emre Ergun, Mustafa Serdar Kalemci, Adnan Simsir, Baris Altay, Mahmut Kusbeci, Fuat Kizilay

    Background/Objectives: Our objective is to evaluate the long-term effects of radical cystectomy and Bricker ileal conduit urinary diversion on upper urinary tract function and structure, with a specific focus on radiological and laboratory changes in renal function. Methods: A retrospective analysis was conducted of 120 patients who underwent radical cystectomy (RC) and Bricker ileal conduit urinary diversion between 2010 and 2024. Clinical, laboratory, and radiological data were assessed over a 24-month follow-up period. Renal parenchymal thickness, kidney volumes, and hydronephrosis grades were analyzed, and the relationship between interventions and renal outcomes was examined. Results: Postoperative follow-up showed a progressive decrease in renal parenchymal thickness and kidney volume, particularly in the left kidney. Hydronephrosis occurred in both renal units, with higher rates on the left side. Despite these changes, only a subset of patients required intervention, typically due to sepsis, acute renal failure, or pain. No significant deterioration in median estimated glomerular filtration rate values was observed; however, patients with interventions showed higher anteroposterior diameter/parenchymal thickness ratios, suggesting increased parenchymal damage. Conclusions: Following radical cystectomy and Bricker ileal conduit diversion, mild to moderate hydronephrosis is not uncommon and does not always necessitate intervention, especially in patients without clinical symptoms. Radiological parameters like renal parenchymal thickness and kidney volume may be valuable for monitoring renal deterioration. Careful follow-up and selective intervention are crucial in preserving renal function in this patient group.

  • Preliminary outcomes of sacral neuromodulation applications: Tertiary-center experience in Türkiye

    by Burcu Özalp, Mustafa Ozan Horsanalı, Meltem Uyar, Can Eyigör, Hüsnü Yılmaz, Adnan Şimşir

    Aim: Sacral neuromodulation (SNM) is a minimally invasive treatment option for various lower urinary tract symptoms (LUTS) and bowel dysfunctions. Despite its widespread use, the exact mechanism of action and optimal patient selection remain unclear. This study aimed to report the outcomes of SNM in patients treated at tertiary health centers in Türkiye.Materials and Methods: A retrospective analysis was conducted on 16 patients who underwent SNM for LUTS, bowel dysfunction, or chronic pelvic pain between 2017 and 2022. Patient characteristics, primary diagnosis, implantation duration, complications, and symptom improvement were recorded. Urinary symptoms were assessed using the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF). Statistical analyses were performed using SPSS Statistics 26.0.Results: The mean age of the patients was 42.4 ± 11.9 years, with a mean BMI of 25.5 ± 5.4 kg/m². The mean duration of symptoms was 12.6 ± 10.5 years, and the mean age at implantation was 40.2 ± 11.1 years. SNM was primarily performed for idiopathic lower urinary tract dysfunction (87.5% of patients) and faecal incontinence (12.5%). The mean ICIQ-SF score significantly decreased from 13.64 ± 7.61 before implantation to 7.50 ± 7.51 after implantation (p = 0.003). A complication requiring surgical intervention occurred in 12.5% of patients.Conclusion: This study demonstrates that SNM is effective in improving symptoms associated with LUTS and bowel dysfunction, as evidenced by the significant reduction in ICIQ-SF scores. However, a notable complication rate was observed, highlighting the importance of appropriate patient selection and ongoing follow-up. Further studies with larger cohorts and longer follow-up are warranted to evaluate the long-term outcomes and safety profile of SNM.

  • Open Access

    The Role of Urinary Secretory Immunoglobulin A in the Pathophysiology of Interstitial Cystitis

    by Turan Ozdemir, Bayram Aliyev, Kasim Emre Ergun, Serdar Kalemci, Fuat Kizilay, Elif Azarsiz, Adnan Simsir

    Purpose: This study aimed to determine whether urinary secretory immunoglobulin A (sIgA) levels differ between patients with bladder pain syndrome/interstitial cystitis (BPS/IC) and healthy controls, and to assess whether urinary sIgA is linked to mucosal immune mechanisms that may contribute to BPS/IC pathophysiology.Methods: A single-center, cross-sectional study was conducted between April and June 2020 at the Department of Urology, Ege University Faculty of Medicine. Forty female patients with BPS/IC and 40 healthy controls were enrolled. Symptom severity in the BPS/IC group was evaluated using the O’Leary-Sant Interstitial Cystitis Symptom and Problem Index. Patients with active urogenital infections, a history of bladder cancer, or prior pelvic radiotherapy were excluded. Urine samples were collected in sterile containers, centrifuged, and stored at -80°C before sIgA measurement using a commercial enzyme-linked immunosorbent assay kit. Correlations between continuous variables were examined with Spearman rank correlation coefficients.Results: Urinary sIgA levels were not significantly different between the BPS/IC group (mean±standard deviation: 0.96±1.5 μg/mL) and healthy controls (0.53±0.7 μg/mL) (P=0.173). Subgroup analyses within the BPS/IC cohort showed that smokers had significantly lower urinary sIgA levels (median [range], 0.001 [0.000–0.082] μg/mL) compared with nonsmokers (median [range], 0.720 [0.000–6.850] μg/mL) (P=0.004). Conversely, patients with cardiac comorbidities had significantly higher urinary sIgA levels (median [range], 0.820 [0.100–6.850] μg/mL) than those without cardiac disease (median [range], 0.213 [0.000–2.300] μg/mL) (P=0.015).Conclusions: Although no significant differences in urinary sIgA levels were observed between BPS/IC patients and healthy controls, subgroup analyses identified associations with smoking and cardiac comorbidities. These findings suggest that sIgA may be relevant to BPS/IC pathophysiology and highlight the potential of mucosal immune biomarkers. Larger studies are warranted to further clarify the role of sIgA in BPS/IC.


  • Open Access

    Prostat Hastalıklarına Yönelik Tedaviler Sonrası İdrar Kaçırma

    by Kasım Emre Ergün, Adnan Şimşir

  • Open Access

    İşlevsel Üroloji ve Kadın Ürolojisi

    by Eda Tokat Şahin, Burak Çıtamak, Alkan Çubuk, Bülent Çetinel, Ramazan Kozan, Bedreddin Seçkin, Eyüp Burak Sancak, Mehmet Kırdar, Murat Can Karaburun, Mustafa Özgür Tan, et al.

  • Open Access

    PSA dansitesinin robotik radikal prostatektomi sonuçlarına etkisinin incelenmesi

    by Alp Akyol, Kasım Emre Ergün, Serdar Kalemci, Adnan Şimşir, Fuat Kızılay

    Amaç: Prostat spesifik antijen dansitesi (PSAD), prostat kanseri tanısında kullanılan serum prostat spesifik antijen (PSA) düzeyinin prostat volümüne oranlanması ile elde edilen tanısal bir belirteçtir. Prostat büyümesi ile PSA düzeylerindeki artışın korele olması nedeniyle tanısal değerlendirmede bu oran sıklıkla kullanılmaktadır ancak cerrahi sonuçların öngörülmesinde kullanılmamaktadır. Bu çalışmanın amacı, lokalize prostat kanseri için robotik radikal prostatektomi geçiren hastalarda PSA dansitesinin cerrahi sonuçlar ve postoperatif komplikasyonlar üzerindeki etkisini değerlendirmektir. Gereç ve Yöntem: Bu retrospektif kohort çalışması, Temmuz 2020 ile Haziran 2022 arasında robotik RP uygulanan 154 hastanın verilerini analiz etmiştir. PSAD, preoperatif PSA düzeyinin (ng/mL) transrektal ultrason (TRUS) veya multiparametrik MRG ile elde edilen prostat hacmine (mL) oranı olarak hesaplanmıştır. Elektronik dosya arşivi taraması ile toplanan veriler demografik bilgiler, preoperatif PSA düzeyleri, prostat hacmi, cerrahi parametreler ve postoperatif sonuçları içermektedir. Bulgular: Hastaların yaş ortalaması 65 (6,69) olup, yaş aralığı 46 ile 80 arasındadır. Preoperatif PSA düzeyleri 2.19 ile 35.4 ng/mL arasında değişmekte ve ortalama 7,75 (4,73) ng/mL olarak bulunmuştur. Prostat hacmi ortalama 47,73 (16,1) mL'dir. PSAD değerlerinin dağılımında hastaların %18,8'i düşük risk, %34,4'ü orta-düşük risk, %22,1'i orta-yüksek risk ve %24,7'si yüksek risk grubundadır. Daha yüksek PSAD ile pozitif cerrahi sınır oranları %18,75, %31,91, %44,12 ve %51,22 olarak saptanmıştır. PSAD'nin vezikoüretral anastomoz stenozu (VUAS) (p=0.8) veya anastomoz kaçakları (p=0.9) üzerinde anlamlı bir etkisi bulunmamıştır. Lojistik regresyon analizi, PSAD (katsayı 3.02, p=0.051) ve T3a kanserin (katsayı 1.48, p=0.018) pozitif cerrahi sınırların anlamlı prediktörleri olduğunu göstermiştir. ROC eğrisi analizinde, PSAD'nin AUC değerinin (0.65), T3a kanserin AUC değerinden (0.55) daha yüksek olduğu saptanmış olup bu durum PSAD’nin T3a kanserden daha iyi bir pozitif cerrahi sınır belirteci olabileceğini göstermektedir. Sonuç: Bu çalışma, robotik radikal prostatektomi geçiren hastalarda yüksek PSAD'nin pozitif cerrahi sınır riskini artırdığını ve cerrahi sonuçları öngörmede önemli bir biyobelirteç olabileceğini göstermektedir. Ancak, PSAD'nin postoperatif komplikasyonlar üzerinde anlamlı bir etkisi yoktur, bu da daha fazla araştırmaya ihtiyaç olduğunu göstermektedir. PSAD, cerrahi sonuçların iyileştirilmesinde önemli bir rol oynayabilir.

  • Üst üriner sistem ürotelyal karsinomlarinda tümör boyutu ve yerleşimi sağ kalımı etkiler mi?

    by Serdar Kalemci̇, Kasım Emre ERGÜN, Fuat Kizilay, Adnan Şi̇mşi̇r, Timur Köse

    Aim: This study aimed to evaluate the effect of tumor location based on clinicopathologic features on cancer-specific survival (CSS) of patients who were treated surgically for locally/locally advanced upper tract urothelial carcinoma (UTUC). Materials and Methods: A single-center series of 145 patients with UTUC who underwent radical nephroureterectomy between May 2010 and August 2019 were included in the study. Patients were stratified based on the location of the tumor as renal pelvis and ureter located tumor. Clinicopathologic characteristics and oncological outcomes were compared according to tumor location and CSS rates after surgery were graphically explored using Kaplan–Meier curves. Results: At a mean follow-up time of 41.8 (4-124) months after surgery, 65 patients (44.8%) died from UTUC. Kaplan-Meier curves showed that tumor location was not associated with CSS in the analysis performed according to tumor stage, grade, and size. In the analysis that was conducted without regard to tumor location, worse CSS was found for patients with pT3 disease versus those with ≤pT2 and with high-grade tumors versus those with low-grade (p=0.025 and p=0.011, respectively). Conclusion: Tumor location was not associated with CSS in any of the analyses. Regardless of tumor location, patients with pT3 disease and high-grade tumors, have a worse prognosis. Further studies on prognostic factors are needed to evaluate the advantages of these factors in the management of patients with UTUC.

  • Open Access

    Analysis of risk factors of abdominal wound dehiscence after radical cystectomy

    by Serdar Kalemci, Kasim Emre Ergun, Fuat Kizilay, Bugra Yildiz, Adnan Simsir

    OBJECTIVE: Wound dehiscence is associated with high morbidity and mortality. This study aimed to analyze the risk factors and comorbidities in the patients undergoing radical cystectomy with early postoperative wound dehiscence.METHODS: In all, 539 patients with bladder cancer who underwent radical cystectomy and urinary diversion at a single center between January 2008 and January 2022 were included in the study. The data related to the demographics, medical history, and perioperative clinical features were reviewed. Univariate and multivariate regression analysis was performed to identify risk factors for wound dehiscence.RESULTS: The mean age of the patients was 64.2 years (22-91). The mean body mass index was 26.4 kg/m2 (18.7-35.4). Wound dehiscence was observed in 43 (7.9%) of 539 patients. The patients with wound dehiscence had significantly higher mean BMI (27.8 vs. 26.3, p=0.006), ASA scores (p=0.002), history of chronic obstructive pulmonary disease (30.2 vs. 14.3%, p=0.006), diabetes mellitus (44.2 vs. 17.9%, p=0.003), previous abdominal surgery (18.6 vs. 7.7%, p=0.014), and postoperative ileus (58.1 vs. 16.9%, p=0.006). In the multivariable regression model, diabetes mellitus (odds ratio [OR] 4.9, 95%CI 2.3-10.1; p<0.001), postoperative ileus (OR 8.1, 95%CI 4.1-16.5; p<0.001), and chronic obstructive pulmonary disease (OR 2.6, 95%CI 1.2-5.7; p=0.013) were independent predictors of abdominal wound dehiscence following radical cystectomy. CONCLUSION: Diabetes mellitus, chronic obstructive pulmonary disease, and postoperative ileus were strongly associated with abdominal wound dehiscence following radical cystectomy. Both potential preventive and therapeutic interventions may decrease the risk of wound dehiscence.


  • Open Access

    Postchemotherapy retroperitoneal residual mass resection for germ cell testicular tumors: a single-center experience

    by Serdar Kalemci, Fuat Kizilay, Kasim Emre Ergun, Bayram Aliyev, Adnan Simsir

    Postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) plays an important role in the management of advanced germ cell testicular tumors. Bilateral template lymph node dissection is considered a standard treatment in postchemotherapy residual masses; however, modified unilateral templates have gained acceptance in patients with unilateral residual disease. In this study, we aimed to demonstrate the perioperative and oncological outcomes of the patients with advanced testicular cancer who underwent unilateral modified template PC-RPLND in our center. This is a retrospective study in which patients who underwent PC-RPLND in a referred center between 2004 and 2021 were investigated. All patients had three or four cycles of chemotherapy and retroperitoneal residual masses. Data were retrospectively collected from medical, operative, radiology, and pathology records and analyzed. A total of 57 patients underwent PC-RPLND. The mean age was 32.7±8.1 years (19-50). According to the disease stage at presentation, there were 39 patients with stage 2 and 18 patients with stage 3. The average tumor size after chemotherapy was 57.6±2.7 mm (25-117). The overall complication rate was 35% (20/57 patients). No grade 4 and 5 complications were observed. Pathologic review demonstrated the presence of teratoma in 28 (49.1%) patients, fibrosis and/or necrosis in 15 (26.3%) patients, and viable germ cell tumor in 14 (24.5%) patients. The mean follow-up was 69.4 months (8-201). During follow-up after surgery, 14 (24.5%) deaths occurred due to advanced disease. PC-RPLND is a major component of the management of advanced testicular germ cell cancer. Our study demonstrated that modified unilateral template is an effective and safe procedure in the postchemotherapy setting for selected patients.


  • Open Access

    Comparison of Shockwave Lithotripsy and Laser Ureterolithotripsy for Ureteral Stones

    by Tuncer Bahçeci, Fuat Kızılay, Ahmet Çağ Çal, Adnan Şimşir